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INTRODUCTION
The enormous investment in biomedical research, particularly in randomized trials, may not have led to the improvements in health that were hoped for. [1] [2] [3] It has been estimated that 85% of the worldwide US $240 billion invested in research annually is wasted. 3 In nephrology, there has been substantial research investment into hemodialysis (HD), yet survival rates have not improved correspondingly over the past 40 years and quality of life remains poor even compared with patients with many cancers. [4] [5] [6] [7] This may be partly attributable to what outcomes are selected and reported in trials -a challenge well-recognized across medical specialties. 1, [8] [9] [10] Surrogate endpoints are frequently used in clinical trials because of feasibility, in preference to outcomes that are directly relevant to patients and clinicians. 9, 11, 12 In HD, biochemical markers such as serum phosphorus, calcium, and parathyroid hormone, are commonly reported but are not strongly and consistently associated with mortality, cardiovascular disease (CVD), or quality of life. [13] [14] [15] [16] [17] Patients on HD prioritize outcomes relevant to their well-being and lifestyle -fatigue, ability to travel, ability to work, sleep, anxiety/stress 18, 19 -all largely absent as outcomes reported by HD trials. In addition, the large heterogeneity of outcome measures and potential for outcome reporting bias (where trials selectively report results for outcomes that favor the intervention) undermines the reliability of trial evidence to inform clinicians and patients about the relative effects of interventions. 20 Engaging all stakeholders in establishing a core outcome set, an agreed minimum set of standardized outcomes to be measured and reported in all trials for a specific clinical area 21, 22 , can increase the relevance, efficiency and reliability of trials. Initiatives to develop core outcomes are seen in rheumatology and oncology, and have demonstrated improvements in consistent reporting of relevant outcomes. 10, 23, 24 As part of the international Standardized Outcomes in NephrologyHemodialysis (SONG-HD) initiative, this study aimed to generate a consensus-based prioritized list of outcome domains for people on HD, which will be used to establish a core outcome set that reflects the shared priorities of patients, caregivers and health professionals.
METHODS

Study design
The Delphi method is a technique for achieving consensus among a panel of experts. This process involves sequential surveys, typically conducted over three rounds, answered anonymously and
gives equal influence to all who participate. It was first developed by the RAND Corporation in the 1950's 25 and has since been increasingly used as a valid approach to develop consensus-based core outcomes for clinical trials in various medical specialty areas. 10, 22, [26] [27] [28] The SONG-HD Delphi process is shown in Supplementary Figure S1 .
Participant selection and recruitment
Stakeholders including patients, caregivers/family members, nephrologists, surgeons, nurses, social workers, psychologists, dieticians, pharmacists, policy makers, researchers and industry, with experience or interest in HD were invited to join the Delphi Panel. Participants worldwide were eligible if they were aged over 18 years and able to complete an online survey in English-language.
All participants provided informed consent.
Using an opt-in, snowballing sampling frame, we recruited patients/caregivers through participating hospitals, patient/consumer organizations, and social media listed in Supplementary File S1. Health professionals were recruited via the investigators networks and via emails and newsletters circulated by professional societies (Supplementary File S1). Participants registered their email on www.songinitiative.org prior to the survey launch. Service (HREC2009/6/4.15) approved this study.
Data collection
The 34 outcome domains for the three-round Delphi survey were identified from a systematic review of outcomes reported in trials in HD, stakeholder interviews, and nominal group technique conducted with patients on HD and caregivers. 29, 30 The ordering of outcomes was randomized and included a plain language definition (Supplementary File S2). The survey was reviewed by the SONG Executive Committee and SONG-HD investigators and piloted among 10 patients. The
Delphi survey was completed online via LimeSurvey between September and November, 2015. The online survey administration minimizes data entry error, allows for wider dissemination and is more efficient compared to a paper survey.
Round 1:
Participants rated the importance of each of the 34 outcomes based on a 9-point Likert scale. A score of 7-9 indicated that the outcome was of "critical importance", 4-6 indicated "important but not critical" and 1-3 indicated "limited importance" according to the GRADE process. 31 An option of "unsure" was provided. Participants could enter comments about their choice of ranking for each outcome. In addition, participants could suggest new outcomes that were not included in the survey. Outcomes with a mean and median of less than 7 for patients/ caregivers and health professionals were not included in round 2.
Round 2: Participants reviewed the group scores and their own score for each outcome and re-rated the 29 outcomes using the same 9-point Likert scale. The group scores were displayed in an interactive column graph which showed the distribution of scores for: patients/caregivers, health professionals, and the total sample combined (weighted) (Supplementary Figure S1 ). Instructions on how to read the graph were provided to ensure that participants were able to understand the results. For each outcome, an optional comments box allowed participants to explain reasons for their rating. Outcomes with a mean and median ≤ 7 for patients/ caregivers and health professionals were excluded from round 3.
Round 3:
Participants were asked to re-rate 20 outcomes using the same Likert scale in the previous rounds after viewing the scores, and in addition, de-identified comments (i.e. free text responses from participants relating to reasons for their rankings or observations on the results for each outcome) from round 2. The comments were divided into two boxes: 'Patients and caregivers' and 'Health professionals' with the ability to scroll down and read all comments. A free text box was provided for each outcome so participants could provide additional comments. In addition, participants completed a forced ranking question, using a drag and drop function, to rank outcomes relative to each other.
Data analysis
We used SPSS (IBM; Version 22.0) to calculate descriptive statistics. We calculated the median, mean, and proportion of participants (rating 7-9) for each outcome. The scores were calculated separately for patients/caregivers and health professionals, with the difference in means considered significant at P<0.05 based on the t-test. For the ranking scores, we calculated the median and interquartile range (IQR) for each outcome to determine rank. Any analysis of the total sample was weighted equally between patients/caregivers and health professionals.
Consensus was defined a priori based on the OMERACT definition using proportion scores.
"Consensus in" is defined as greater than or equal to 70% of participants scoring as 7 to 9 and less than 15% participants scoring as 1 to 3. 29 However, as most participants rated all outcomes in round 3 as critically important with scores of 7-9, these criteria resulted in a list of 16 outcomes, which exceeded the recommended 3 to 5 outcomes for a core outcome set. Therefore, the definition and threshold for "consensus in" were revised to determine a maximum of five core outcomes to be considered for the core outcome set.
Definition of consensus
Outcomes from round 1 with a mean and median score greater than or equal to 7 for patients/caregivers and health professionals were included in round 2. This was validated against the proportion of critically important scores (rated 7-9) for each outcome to ensure that important outcomes were not excluded.
Outcomes from round 2 with a mean and median score greater than 7 for patients/caregivers and health professionals were included in round 3. This was validated against the proportion of critically important scores (rated 7-9) for each outcome.
Outcomes included in the potential core outcome set met the following criteria for both patients/caregivers and health professionals: median score greater than or equal to 8; mean score greater than or equal to 7.5; proportion of participants rating the outcome 'critically important' is greater than or equal to 75% and median score is less than 10 in the forced ranking question.
RESULTS
Participant characteristics
In total, 1 181 people from 73 countries participated in round 1 of the Delphi survey including 202 (17%) patients/caregivers and 979 (83%) health professionals. Round 2 included 165 patients/caregivers (17%) and 784 health professionals (83%) from 63 countries. In the third and final round, 150 patients/caregivers (18%) and 688 health professionals (82%) participated. The full survey completion rate was 71%. The participant characteristics are provided in Tables 1 and 2 .
In round 3, 115 (77%) patients/caregivers were aged from 41 to 70 years and 76 (51%) were women. Patients/caregivers were from 14 countries in round 1 (11 countries in round 3). In round 3, Among the 116 (77%) patients on HD, 63 (42%) patients were on in-center HD and 51 (34%) were on home HD. The health professionals included 857 nephrologists (51%), 386 nurses (38%), 53 researchers (5%), and 63 (6%) in other roles. Health professionals were from 72 countries in round 1 (62 countries in round 3).
Delphi scores
Round 1: The means, medians, and proportion of participants rating the outcome 7 -9 (critical importance) for each of the 34 outcomes are shown in Supplementary Table S1 . The top three outcomes rated by patients/caregivers based on mean scores (1 to 9) were: dialysis adequacy (7 The following outcomes were excluded from round 2 as they had a mean or median score of less than 7 (not of critical importance) among both patient/caregiver and health professional groups in round 1: nausea/vomiting, sexual function, restless legs syndrome, itching and cramps. Less than 25% of participants suggested new outcomes in round 1 (Supplementary Table S2 ). These outcomes
were not considered for inclusion in round 2 due to the following reasons: the outcome could not be measured in a clinical trial for the majority of adult patients on HD, the outcome was too broad conceptually or ambiguously defined, and the outcome was described as an intervention. Outcomes which had a mean and median score ≤7 with less than 70% of the sample rating the outcome 7-9 (critical importance) were excluded from round 3: anxiety/stress, food enjoyment, calcium, parathyroid hormone, cognition, sleep, bone health, financial impact and phosphate. Outcomes that met at least two of the following criteria for consensus within both stakeholder groups (median ≥ 8, mean ≥ 7.5, proportion ≥ 75%, and median rank < 10) [ Table 3 ]) were: CVD, mortality, dialysis adequacy, fatigue, and vascular access problems. All participant comments for each outcome are provided in Supplementary File S3.
Changes in scores from round 1 to 3 within stakeholder groups
As shown in Figure 1 , the patient/caregiver mean scores increased between rounds 1 and 3 for the following 7 outcomes: vascular access problems (mean score difference 0.9, P = <0.001), CVD (0.7, P = 0.002), infection/immunity (0.7, P = 0.004), drop in blood pressure (0.6, P = 0.02), mobility (0.6, P = 0.02), target weight (0.6, P = 0.02) and washed out after dialysis (0.5, P = 0.01).
For health professionals, the mean scores increased for 16 outcomes between rounds 1 and 3 ( 
Differences between stakeholder groups
The differences in ratings between stakeholder groups are shown in Figure 3 . Based on the difference in mean scores in round 3, four outcomes were rated higher by patients/caregivers: ability to travel (mean difference 0.9, P <0.001), dialysis-free time (0.5, P <0.001), dialysis adequacy (0.3, P = 0.05) and washed out after dialysis (0.2, P = 0.05).
Health professionals rated 11 outcomes higher compared to patients/caregivers: mortality (mean difference 1.0, P <0.001), hospitalization (1.0, P <0.001), drop in blood pressure (1.0, P <0.001), vascular access problems (0.9, P <0.001), depression (0.9, P <0.001), CVD (0.8, P <0.001), target weight (0.7, P <0.001), infection/immunity (0.4, P = 0.002), potassium (0.4, P = 0.02), ability to work (0.3, P = 0.008), and pain (0.3, P = 0.04).
Forced ranking scores
The results of the forced ranking question are shown in Supplementary 
DISCUSSION
The highest-priority outcomes shared among patients/caregivers and health professionals were vascular access problems, dialysis adequacy, fatigue, CVD, and mortality. Overall, most of these reflect common and high-impact outcomes in the context of HD, which have remained as major challenges in providing care for patients on HD. Frequently reported biochemical outcomes in HD trials, such as phosphate, calcium and parathyroid hormone, were consistently rated to be of lower importance by both stakeholder groups.
Although there was convergence in ratings between patients/caregivers and health professionals across the three rounds of the Delphi, our findings also highlight some mismatches. Outcomes relating to lifestyle (ability to travel, dialysis-free time) and well-being (washed out after dialysis) rated higher among patients/ caregivers compared to health professionals. Research has consistently shown that patients and caregivers prioritize lifestyle-related outcomes over biochemical endpoints. 18, 19, 30 Ability to travel, fatigue/energy and dialysis-free time are important outcomes for patients and caregivers who want to retain normality in their day to day lives and maintain a reasonable quality of life. 19, 30 In a recent discrete choice study, patients were willing to trade off 23 months of life expectancy with home-based dialysis to increase their ability to travel. 32 Biochemical endpoints are less important to patients and caregivers because they are considered intangible or imperceptible.
30
Dialysis adequacy was also rated higher by patients/caregivers. The participant comments (Supplementary File S3) and discussions from the recent SONG-HD consensus workshop on establishing core outcomes in HD 33 , indicates participants conceptualized the term "dialysis adequacy" as a broad quality of life outcome (i.e. dialysis that is adequate for enabling patients to feel well) rather than quantification of urea kinetics, which may explain this apparent divergence. The outcomes rated higher by health professionals (with a mean difference greater than 0.5 in ratings) were: mortality, hospitalization, drop in blood pressure, vascular access problems, depression, CVD, and target weight. This perhaps reflects their perceived primary clinical role in preventing and managing these outcomes which are common among HD patients and awareness of their impact on patients' lives, whereas high-priority outcomes for patients such as ability to travel and dialysis-free time may be seen by health professionals as impractical to measure.
Uremic symptoms such as itching and nausea/vomiting, as well as restless legs syndrome and cramps were rated relatively lower by patients/caregivers in round 1 and were excluded from subsequent rounds. Instead, patients/caregivers gave higher priority to broader outcomes related to lifestyle impact and overall well-being (dialysis-free time, ability to travel, fatigue) rather than specific symptoms. Yet, many patient-reported outcome measures are designed to assess symptoms and few robust and well-validated instruments measure specific patient-important outcomes that have an arguably more pervasive and long-term impact on lifestyle and well-being.
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Furthermore, patients may not report lifestyle problems (e.g. ability to work) which are not articulated in clinical settings as patients may perceive these to be beyond their clinician's control.
The SONG-HD Delphi survey had a large sample size (five times greater than most similar Delphi surveys to establish core outcomes) 23,38,39 and achieved a broad engagement of a range of stakeholders including patients/caregivers, multidisciplinary healthcare providers, policy makers and industry, across 73 countries, and retained a high response rate of 71% by round 3. The process provided a transparent and systematic way to gain consensus on the importance of outcomes to consider for a core outcome set in HD. However, there are some potential limitations. The Delphi survey was conducted online and excludes participants without access to a computer and internet connection. The survey was only available in English-language to retain consistency of meaning and for feasibility, although some participants submitted open-text responses in Spanish-language which were translated. We also acknowledge that detailed analysis of the open-text responses was not conducted and is beyond the scope of the current paper. Given the design of the Delphi survey, we recognize that the results are potentially biased towards participants who are English speaking with access to a computer and internet connection, and who have the ability to use a computer.
We included participants from 73 countries and acknowledge that the majority of participants were from high income countries. We recognize that these outcomes may not be shared by those who did not participate in the study, or by individuals or groups within the study. A study of this type must necessarily accept the views of the majority of participants as representing the consensus position, and will not represent the view of all individuals.
Whilst definitions were provided for each outcome domain, we acknowledge the inevitable interaction between some outcome domains, and participants may have interpreted the outcomes differently. We provided the participant comments to make explicit how the outcomes were conceptualized, and based on these data, we did not note any apparent differences that may have explained variation in prioritization between patients/caregivers and health professionals. The results from the consensus workshop further support this.
33
Currently, there is no core outcome set in chronic kidney disease. The Delphi survey results will be used to establish a core outcome set to be reported in all trials in HD, which is expected to increase the quality and relevance of research. This has been done successfully by the Outcome Measures in Rheumatology (OMERACT) initiative, which has improved the reporting and relevance of outcomes in rheumatology trials. 10, 24 Recent analyses have shown that a higher percentage of trials are now incorporating the OMERACT core outcome set in rheumatology trials.
24
The results of this study were discussed at a recent SONG-HD consensus workshop. To effectively implement a core outcome set in chronic kidney disease, patients/caregivers and health professional participants suggested that outcome measures should be feasible and valid, and take patient priorities into account. 33 Once the core outcome domains have been established, which will be largely informed by the results of this Delphi survey, further work will focus on identifying core outcome measures for the outcome domains.
In summary, the international SONG-HD Delphi study identified a prioritized set of outcome domains for trials in HD based on consensus among key stakeholder groups. The top prioritized outcomes by both patients/caregivers and health professionals were vascular access problems, dialysis adequacy, fatigue, CVD and mortality. Patients/caregivers place highest value on outcomes that will enable them to maintain their day-to-day well-being and lifestyle. The findings will directly inform the development of a core outcome set to be used in HD trials. Ultimately, this will strengthen the relevance and reliability of trial evidence to support shared decision-making for people dependent on HD in order to improve treatment outcomes. 
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